Eli Lilly, TRIUMPH-7 (Obesity/Overweight & Chronic Low Back Pain): A Study to Investigate Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain - November 19, 2025
Sanofi, THESEUS (COPD): Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype - November 19, 2025
Chiesi, TRITON (COPD): A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD - October 29, 2024
AstraZeneca, MIRANDA (COPD): Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease with a History of Exacerbations - October 29, 2024
Eli Lilly (Painful Distal Sensory Polyneuropathy): Effect of LY3848575 versus Placebo in Participants with Painful Distal Sensory Polyneuropathy - October 29, 2024
Avadel, REVITALYZ (Idiopathic Hypersomnia): A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH) - October 29, 2024
Eli Lilly and Company, TRAILRUNNER-ALZ 3 (Alzheimer’s Disease): A Study of Remternetug in Early Alzheimer’s Disease - October 29, 2024
